Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jessica Barochiner has a total of 154 co-authors. Here are the top co-authors by number of shared publications:

  • Lucas S. Aparicio

    Hypertension Section, Internal Medicine Department, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina

    10 shared publications
  • José Alfie

    Hypertension Section, Internal Medicine Department, Hospital Italiano de Buenos Aires

    9 shared publications
  • Margarita S. Morales

    Hypertension Section, Internal Medicine Department, Hospital Italiano de Buenos Aires, Juan D. Perón 4190, C1181ACH, Buenos Aires, Argentina

    9 shared publications
  • Paula E. Cuffaro

    Hypertension Section, Internal Medicine Department, Hospital Italiano de Buenos Aires, Buenos Aires. Argentina

    9 shared publications
  • Gabriel D. Waisman

    Hypertension Section, Internal Medicine Department, Hospital Italiano de Buenos Aires, Juan D. Perón 4190, C1181ACH, Buenos Aires, Argentina

    8 shared publications
  • Marcelo A. Rada

    Hypertension Section, Internal Medicine Department, Hospital Italiano de Buenos Aires, Juan D. Perón 4190, C1181ACH, Buenos Aires, Argentina

    7 shared publications

Latest Publications

  • Genomic Landscape of Metastatic Urothelial Cancer in a Multicenter Cohort From Argentina

    by Federico Cayol, Iván Macharashvili, Jessica Barochiner, María Pía Dominguez, Emiliano Menna, Pablo Jose Perez Mesa, Julieta Pandolfi, Omar Carranza, Rodrigo Sanchez, Andrea Marchioni, et al.

    PURPOSE: The genomic landscape of advanced urothelial carcinoma (aUC) has enabled the development of targeted therapies; however, real-world data from Latin America remain limited. MATERIALS AND METHODS: We conducted a multicenter retrospective study including patients with aUC who underwent next-generation sequencing on tumor tissue. Molecular alterations were classified according to the European Society for Medical Oncology (ESMO) Scale for Clinical Actionability of Molecular Targets (ESCAT). RESULTS: A total of 107 patients were included. Overall, 68 patients (63.6%) harbored at least one potentially actionable molecular alteration. Among these, 34 patients (31.8%) exhibited ESCAT level I alterations, most commonly involving FGFR3 mutations/fusions and ERBB2 amplification. CONCLUSION: A clinically meaningful proportion of Argentine patients with aUC harbor ESCAT level I actionable alterations, supporting the incorporation of routine genomic profiling into clinical practice.

  • Open Access

    De la técnica al todo: enfoque sistémico del reemplazo valv

    by Germán A. Fortunato, Jessica Barochiner

    In recent decades, the number of patients with aortic valve disease requiring aortic valve replacement (AVR) has increased due to longer life expectancy. Many of these patients, especially those who are elderly and have comorbidities, face high preoperative risk. The complexity of cardiovascular disease and the adaptation of these patients to the intervention require a comprehensive and holistic approach, considering biological, genetic, and psychosocial factors. This article addresses the importance of understanding AVR as part of a complex system, emphasizing the interaction between multiple elements of the cardiovascular system such as the myocardium, conduction system, and coronary circulation, which affect surgical outcomes. It also highlights how the selection of heart valve prosthesis and other unpredictable factors can influence postoperative mortality, which should not be viewed as a simple cause-and-effect phenomenon. The use of advanced technologies, such as artificial intelligence, can improve outcomes in the preoperative, intraoperative, and postoperative phases of treatment. In conclusion, to improve outcomes in patients undergoing surgical RVA, it is essential to adopt a systemic approach, within the framework of complexity theory, that integrates innovative technologies and considers the individual characteristics of each patient. This could contribute to reduce in-hospital mortality.

  • Open Access

    De la técnica al todo: enfoque sistémico del reemplazo valvular aórtico con válvulas tradicionales y de rápido implante

    by Germán Fortunato, Jessica Barochiner

    In recent decades, the number of patients with aortic valve disease requiring aortic valve replacement (AVR) has increased due to longer life expectancy. Many of these patients, especially those who are elderly and have comorbidities, face high preoperative risk. The complexity of cardiovascular disease and the adaptation of these patients to the intervention require a comprehensive and holistic approach, considering biological, genetic, and psychosocial factors. This article addresses the importance of understanding AVR as part of a complex system, emphasizing the interaction between multiple elements of the cardiovascular system such as the myocardium, conduction system, and coronary circulation, which affect surgical outcomes. It also highlights how the selection of heart valve prosthesis and other unpredictable factors can influence postoperative mortality, which should not be viewed as a simple cause-and-effect phenomenon. The use of advanced technologies, such as artificial intelligence, can improve outcomes in the preoperative, intraoperative, and postoperative phases of treatment. In conclusion, to improve outcomes in patients undergoing surgical RVA, it is essential to adopt a systemic approach, within the framework of complexity theory, that integrates innovative technologies and considers the individual characteristics of each patient. This could contribute to reduce in-hospital mortality.

  • Open Access

    May Measurement Month 2021: an analysis of blood pressure screening results from Argentina

    by Jessica Barochiner, Fortunato García Vázquez, Pedro Becerra, Cristina Rojas, Ricardo Pesenti, Noemi A Mazzei, Arnoldo Kalbermatter, Analía Fuentes, Mariana Fita, Diego Márquez, et al.

    Hypertension continues to be the leading cause of death and disability in the industrialized world, with a high level of unawareness and unacceptably poor control rates. Therefore, the Argentinian Society of Hypertension, in association with the May Measurement Month (MMM) charity, implemented an awareness campaign during May 2021. A voluntary cross-sectional survey was carried out during the month of May 2021 in public spaces and health centres across 29 cities in Argentina. Hypertension was defined as systolic blood pressure (BP) ≥ 140 mmHg and/or diastolic BP ≥ 90 mmHg based on the mean of the second and third of three BP measurements or in those volunteers on treatment for high BP. Statistical analysis including multiple imputation followed the MMM protocol. A total of 26 070 individuals (average age 53.4 years, 14 816 women and 11 254 men) were evaluated. The age- and sex-standardized mean BP was 125.1/77.6 mmHg. Of all participants, 54.4% had hypertension. Although 79.8% of the hypertensive participants were aware of their condition and 76.9% were on antihypertensive treatment, only 42.5% of all individuals with hypertension had their BP controlled (<140/90 mmHg). Of those on antihypertensive medication, 55.3% were controlled. The low level of hypertension control highlights the critical need for community-based prevention strategies to increase the awareness and control of hypertension, thereby reducing the enormous health burden attributed to this condition.


  • Open Access

    Prevalence and Characteristics of Isolated Nocturnal Hypertension and Masked Nocturnal Hypertension in a Tertiary Hospital in the City of Buenos Aires

    by Jessica Barochiner, Romina R. Díaz, Rocío Martínez

    Isolated nocturnal hypertension (INH) and masked nocturnal hypertension (MNH) increase cardiovascular risk. Their prevalence and characteristics are not clearly established and seem to differ among populations. We aimed to determine the prevalence and associated characteristics of INH and MNH in a tertiary hospital in the city of Buenos Aires. We included 958 hypertensive patients ≥ 18 years who underwent an ambulatory blood pressure monitoring (ABPM) between October and November 2022, as prescribed by their treating physician to diagnose or to assess hypertension control. INH was defined as nighttime BP ≥ 120 mmHg systolic or ≥70 diastolic in the presence of normal daytime BP (<135/85 mmHg regardless of office BP; MNH was defined as the presence of INH with office BP < 140/90 mmHg). Variables associated with INH and MNH were analyzed. The prevalences of INH and MNH were 15.7% (95% CI 13.5–18.2%) and 9.7 (95% CI 7.9–11.8%), respectively. Age, male sex, and ambulatory heart rate were positively associated with INH, whereas office BP, total cholesterol, and smoking habits showed a negative association. In turn, diabetes and nighttime heart rate were positively associated with MNH. In conclusion, INH and MNH are frequent entities, and determination of clinical characteristics such as those detected in this study is critical since this might contribute to a more appropriate use of resources.


  • Prognostic value of home blood pressure monitoring in patients under antihypertensive treatment

    by Jessica Barochiner, Lucas S. Aparicio, Rocío Martínez, José Boggia

    The prognostic value of home blood pressure monitoring (HBPM) has been investigated in several studies in the general population, demonstrating its independent association with cardiovascular events. However, in the case of treated hypertensive subjects, evidence is controversial. Our purpose was to evaluate the prognostic value of HBPM in this population. Medicated hypertensive patients who performed a 4-day HBPM (Omron® HEM-705CP-II) between 2008 and 2015 were followed up for a median of 5.9 years, registering the occurrence of a composite primary outcome of fatal and non-fatal cardiovascular events. Cox regression models were used to analyze the prognostic value of HBPM, considering 4-day measurements, discarding the first day, and analyzing morning, afternoon and evening periods separately. We included 1582 patients in the analysis (33.4% men, median age 70.8 years, on an average of 2.1 antihypertensive drugs). During follow-up, 273 events occurred. HBPM was significantly associated with cardiovascular events in all five scenarios in the unadjusted models. When adjusting for office BP and other cardiovascular risk factors, the association remained marginally significant for the 4-day period, discarding first-day measurements HBPM (HR 1.04 [95% CI 1–1.1] and 1.04 [95% CI 1–1.1], respectively) and statistically significant for all separate periods of measurement: HR 1.32 (95% CI 1.01–1.72); 1.33 (95% CI 1.02–1.72); and 1.30 (95% CI 1.01–1.67), for morning, afternoon and evening, respectively. When analyzing separately fatal and non-fatal events, statistical significance was held for the former only. In conclusion, HBPM is an independent predictor of cardiovascular events in hypertensives under treatment.


  • Open Access

    Risk Stratification by Cross-Classification of Central and Brachial Systolic Blood Pressure

    by Yi-Bang Cheng, Lutgarde Thijs, Lucas S. Aparicio, Qi-Fang Huang, Fang-Fei Wei, Yu-Ling Yu, Jessica Barochiner, Chang-Sheng Sheng, Wen-Yi Yang, Teemu J. Niiranen, et al.

    Background: Whether cardiovascular risk is more tightly associated with central (cSBP) than brachial (bSBP) systolic pressure remains debated, because of their close correlation and uncertain thresholds to differentiate cSBP into normotension versus hypertension. Methods: In a person-level meta-analysis of the International Database of Central Arterial Properties for Risk Stratification (n=5576; 54.1% women; mean age 54.2 years), outcome-driven thresholds for cSBP were determined and whether the cross-classification of cSBP and bSBP improved risk stratification was explored. cSBP was tonometrically estimated from the radial pulse wave using SphygmoCor software. Results: Over 4.1 years (median), 255 composite cardiovascular end points occurred. In multivariable bootstrapped analyses, cSBP thresholds (in mm Hg) of 110.5 (95% CI, 109.1–111.8), 120.2 (119.4–121.0), 130.0 (129.6–130.3), and 149.5 (148.4–150.5) generated 5-year cardiovascular risks equivalent to the American College of Cardiology/American Heart Association bSBP thresholds of 120, 130, 140, and 160. Applying 120/130 mm Hg as cSBP/bSBP thresholds delineated concordant central and brachial normotension (43.1%) and hypertension (48.2%) versus isolated brachial hypertension (5.0%) and isolated central hypertension (3.7%). With concordant normotension as reference, the multivariable hazard ratios for the cardiovascular end point were 1.30 (95% CI, 0.58–2.94) for isolated brachial hypertension, 2.28 (1.21–4.30) for isolated central hypertension, and 2.02 (1.41–2.91) for concordant hypertension. The increased cardiovascular risk associated with isolated central and concordant hypertension was paralleled by cerebrovascular end points with hazard ratios of 3.71 (1.37–10.06) and 2.60 (1.35–5.00), respectively. Conclusions: Irrespective of the brachial blood pressure status, central hypertension increased cardiovascular and cerebrovascular risk indicating the importance of controlling central hypertension.


  • White Coat Uncontrolled Hypertension in Teleconsultation: A New and Frequent Entity

    by Jessica Barochiner, Marcos J. Marín, Jorge J. Janson, Patricia R. Conti, Rocío Martínez, Gabriel Micali, Isabel E. Conte, Fernando Plazzotta

    Introduction Cardiovascular risk seems not to be greater in patients with white coat uncontrolled hypertension (WUCH) than in patients with sustained blood pressure (BP) control. Therefore, its detection is important to avoid overtreatment. The COVID-19 pandemic determined a massive migration of hypertension consultations from the face-to-face modality to teleconsultations, and it is unknown whether WUCH exists in this context. Aim We aimed to evaluate the prevalence of WUCH through home BP monitoring (HBPM) in treated hypertensive patients evaluated by teleconsultation. Methods We included treated hypertensive patients that owned a digital BP monitor. During teleconsultation, patients were asked to perform two BP measurements and then a 7-day HBPM, using the same device. Patients were classified as having WUCH if BP was ≥ 140 and/or 90 mmHg in teleconsultation and < 135/85 mmHg on HBPM. The prevalence of WUCH and its 95% confidence interval were estimated. One-way ANOVA, the Chi-square test or Fisher’s exact test were used to compare the characteristics of these patients with the other groups. Results We included 341 patients (45.2% male, mean age 62.3 years). The prevalence of WUCH was 33.1% (95% CI 28.3–38.3%). Significant differences were found in terms of age, the number of antihypertensive drugs and the use of calcium channel blockers, all lower in the WUCH group as compared with the groups with elevated BP on HBPM. Conclusion WUCH exists in teleconsultation and is very frequent. It can be easily detected though HBPM, thus avoiding overmedication, and its potential impact on side-effects and health costs.


  • Open Access

    The International Database of Central Arterial Properties for Risk Stratification: Research Objectives and Baseline Characteristics of Participants

    by Lucas S Aparicio, Qi-Fang Huang, Jesus D Melgarejo, Dong-Mei Wei, Lutgarde Thijs, Fang-Fei Wei, Natasza Gilis-Malinowska, Chang-Sheng Sheng, José Boggia, Teemu J Niiranen, et al.

    OBJECTIVE: To address to what extent central hemodynamic measurements, improve risk stratification, and determine outcome-based diagnostic thresholds, we constructed the International Database of Central Arterial Properties for Risk Stratification (IDCARS), allowing a participant-level meta-analysis. The purpose of this article was to describe the characteristics of IDCARS participants and to highlight research perspectives. METHODS: Longitudinal or cross-sectional cohort studies with central blood pressure measured with the SphygmoCor devices and software were included. RESULTS: The database included 10,930 subjects (54.8% women; median age 46.0 years) from 13 studies in Europe, Africa, Asia, and South America. The prevalence of office hypertension was 4,446 (40.1%), of which 2,713 (61.0%) were treated, and of diabetes mellitus was 629 (5.8%). The peripheral and central systolic/diastolic blood pressure averaged 129.5/78.7 mm Hg and 118.2/79.7 mm Hg, respectively. Mean aortic pulse wave velocity was 7.3 m per seconds. Among 6,871 participants enrolled in 9 longitudinal studies, the median follow-up was 4.2 years (5th–95th percentile interval, 1.3–12.2 years). During 38,957 person-years of follow-up, 339 participants experienced a composite cardiovascular event and 212 died, 67 of cardiovascular disease. CONCLUSIONS: IDCARS will provide a unique opportunity to investigate hypotheses on central hemodynamic measurements that could not reliably be studied in individual studies. The results of these analyses might inform guidelines and be of help to clinicians involved in the management of patients with suspected or established hypertension.